MedPath

Digital thErapy For Improved tiNnitus carE Study (DEFINE)

Not Applicable
Conditions
Tinnitus
Ear, Nose and Throat
Registration Number
ISRCTN99577932
Lead Sponsor
Oto Health Ltd
Brief Summary

2024 Protocol article in https://doi.org/10.1371/journal.pone.0292562 (added 08/01/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
196
Inclusion Criteria

1. Aged 18 years or over
2. Experienced tinnitus symptoms for at least 3 months and self-assessed as having a significant impact on quality of life
3. Have access to a smartphone
4. Able and willing to give consent for the study prior to participation
5. Able to speak and read English to a sufficient level

Exclusion Criteria

1. Tinnitus with potential red flag” symptoms i.e. unilateral or pulsatile tinnitus (assessed via a red flag checklist during the screening call)
2. Significant mental health problems e.g. history of suicidal ideation or requirement for psychiatric/psychological support beyond primary care level
3. Have required hospitalisation for depression or taking antipsychotic drug
4. Currently taking part in another clinical trial for hearing/tinnitus
5. Awaiting surgical intervention for hearing/tinnitus
6. Previously undergone tinnitus therapy of any type e.g. CBT or TRT
7. Pregnant and breastfeeding women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath